» Articles » PMID: 37333676

The 5XFAD Mouse Model of Alzheimer's Disease Displays Age-dependent Deficits in Habituation to a Novel Environment

Overview
Journal Aging Brain
Publisher Elsevier
Specialty Geriatrics
Date 2023 Jun 19
PMID 37333676
Authors
Affiliations
Soon will be listed here.
Abstract

Habituation is a form of learning characterized by a decrement in responsiveness to a stimulus that is repeated or prolonged. In rodents, habituation to a novel environment is characterized by a decrease in locomotion over time spent in a novel environment. Habituation to a novel environment is dependent on hippocampal function, suggesting that habituation behavior may be a relevant readout for hippocampal-dependent memory deficits that are characteristic of Alzheimer's disease (AD). Current assays that measure hippocampal-dependent memory in preclinical animal models of AD have not accurately predicted the cognitive protection of novel interventions in human trials. Here, we tested whether a behavioral habituation paradigm could detect age-associated changes in a common preclinical mouse model of AD-like amyloid pathology, the 5XFAD mouse. We exposed 5XFAD mice and age-matched wild-type (WT) littermates at 3, 6, and 9 months of age to a novel environment over two sessions separated by 24 h and measured their locomotion. WT mice habituated to the novel environment over time, while 5XFAD mice displayed age-dependent deficits in behavioral habituation. We replicated our results using publicly available open field data from 5XFAD and late-onset AD mouse models with TREM2*R47H and APOE4 mutations. Overall, we present behavioral habituation as a potentially sensitive task to assess age-associated behavioral deficits in 5XFAD mice and other mouse models of AD that could be used to test the preclinical efficacy of novel AD therapeutics.

Citing Articles

Ideal animal models according to multifaceted mechanisms and peculiarities in neurological disorders: present and challenges.

Lamichhane S, Seo J, Jeong J, Lee S, Lee S Arch Pharm Res. 2024; 48(1):62-88.

PMID: 39690343 DOI: 10.1007/s12272-024-01527-9.


Hyperactive neuronal networks facilitate tau spread in an Alzheimer's disease mouse model.

Barbour A, Hoag K, Cornblath E, Chavez A, Lucas A, Li X bioRxiv. 2024; .

PMID: 39677701 PMC: 11642807. DOI: 10.1101/2024.12.01.625514.


Targeting Neuroinflammation and Apoptosis: Cardamonin's Cognitive Benefits in Alzheimer's 5XFAD Mice.

Smail S Neurochem Res. 2024; 50(1):57.

PMID: 39673650 DOI: 10.1007/s11064-024-04308-4.


Spatiotemporal Dysregulation of Neuron-Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the Mouse Model of Alzheimer's Disease.

Ianni M, Corraliza-Gomez M, Costa-Coelho T, Ferreira-Manso M, Inteiro-Oliveira S, Aleman-Serrano N Int J Mol Sci. 2024; 25(17).

PMID: 39273422 PMC: 11394861. DOI: 10.3390/ijms25179475.


Behaviour Hallmarks in Alzheimer's Disease 5xFAD Mouse Model.

Padua M, Guil-Guerrero J, Lopes P Int J Mol Sci. 2024; 25(12).

PMID: 38928472 PMC: 11204382. DOI: 10.3390/ijms25126766.


References
1.
Gu L, Wu D, Tang X, Qi X, Li X, Bai F . Myelin changes at the early stage of 5XFAD mice. Brain Res Bull. 2017; 137:285-293. DOI: 10.1016/j.brainresbull.2017.12.013. View

2.
Vianna M, Alonso M, Viola H, Quevedo J, De Paris F, Furman M . Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn Mem. 2000; 7(5):333-40. PMC: 311352. DOI: 10.1101/lm.34600. View

3.
Forner S, Kawauchi S, Balderrama-Gutierrez G, Kramar E, Matheos D, Phan J . Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease. Sci Data. 2021; 8(1):270. PMC: 8519958. DOI: 10.1038/s41597-021-01054-y. View

4.
Lyons C, Bartolomucci A . Stress and Alzheimer's disease: A senescence link?. Neurosci Biobehav Rev. 2020; 115:285-298. PMC: 7483955. DOI: 10.1016/j.neubiorev.2020.05.010. View

5.
Kotredes K, Oblak A, Pandey R, Lin P, Garceau D, Williams H . Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H. Front Aging Neurosci. 2021; 13:735524. PMC: 8544520. DOI: 10.3389/fnagi.2021.735524. View